Case Study Interprets Continuous Process Verification Guidance - - BioPharm International

ADVERTISEMENT

Case Study Interprets Continuous Process Verification Guidance


BioPhorum Operations Group (BPOG) has published a resource to help the biopharmaceutical industry deliver a high quality, consistent approach to continued process verification (CPV). The resource, a case study developed in response to Stage 3 process verification guidance from the FDA, is designed to help companies develop their own CPV approach by providing best practices and guidance on how to implement and demonstrate effective process validation.

The 100-page case study, “Continued Process Verification: An Industry Position Paper with Example Plan,” was written by subject matter experts from major biotech manufacturers. The document describes the thought processes behind the creation of a CPV plan.  Containing a model plan based on a generic monoclonal antibody (mAb) production process, the case study makes it clear how critical process parameters are identified, analyzed, and reported for every step in the process.

Source: BioPhorum Operations Group

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Novartis Reports Positive Results for Secukinumab in Ankylosing Spondylitis Trials
October 23, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Author Guidelines

Click here